CRP and cancer: The combination of C-reactive protein and albumin, termed the Glasgow Prognostic Score (GPS), has been reported to be informative of the nutritional risk of patients with cancer [33] and has been used successfully to predict survival in patients with a variety of common solid tumors, both in the operable [10] and advanced inoperable setting [9].